Robert K. Maloney, MD

How will ophthalmologists watch the eclipse?
How will ophthalmologists watch the eclipse?Ophthalmologists all know how to safely watch an eclipse, but how will ophthalmologists around the country be participating in and observing the event?
New wavefront indication enhances treatment for mixed astigmatism
New wavefront indication enhances treatment for mixed astigmatismThe approved use of wavefront-guided technology for mixed astigmatism may help ophthalmologists to reach another potential group of patients.
How has ophthalmology changed in 2016?
How has ophthalmology changed in 2016?As the end of the year approaches, we wanted to take a look back at the predictions our Editorial Advisory Board members made for 2016 and see how far we’ve come in the last 12 months.
Managing dislocated IOLs with scleral suture fixation
Managing dislocated IOLs with scleral suture fixationLos Angeles—Scleral suture fixation of the IOL-capsular tension ring (CTR)-capsular bag complex is an effective option for surgical repositioning of a dislocated IOL, according to Robert K. Maloney, MD.
How will ophthalmology evolve in 2016?
How will ophthalmology evolve in 2016?Ophthalmology Times spoke with its Editorial Advisory Board members to get their thoughts on how the field of ophthalmology is growing, what advances they are highly anticipating, and what major hurdles ophthalmologists will face in 2016. A special thanks to Peter J. McDonnell, MD, Randall Olson, MD, Andrew G. Lee, MD, Sharon Fekrat, MD, and Robert K. Maloney, MD, for giving us a sneak peak at what the new year will bring.
Was 2015 the year of inlays, FLACS, or something else?While 2015 may not have been the year for ground-breaking introductions or trials in the field of refractive surgery, plenty of improvements have kept the procedure an evolving process, Ophthalmology Times editorial advisory board members said.
Drug therapies improving refractive outcomesLines continue to blur as to what constitutes refractive surgery, and likely will continue to blur well into the future. Multiple compounds—phenylephrine and ketorolac 1%/0.3%, (Omidria, Omeros) and the “Dropless” line (Tri-Moxi/Tri-moxi-Vanc, Imprimis Pharmaceuticals)—are designed for use in cataract surgery, but their goal is to improve refractive outcomes. 2015 was the year they started to get some serious attention.
Laser refractive lens surgery: Is it safe or isn’t it safe?Surgeons with experience using the femtosecond laser for refractive lens surgery discuss the safety benefits and challenges accompanying its use.